The formylpeptide receptor (FPR) family of G-protein coupled receptors (GPCR) contributes to the localization and activation of tissue-damaging leukocytes at sites of chronic inflammation.  FPR ligands trigger a variety of biologic activities in myeloid cells, including chemokinesis, chemotaxis, cytokine production and superoxide generation.  It has been proposed that a primary FPR function is to promote trafficking of phagocytic myeloid cells to sites of infection and tissue damage where they exert anti-bacterial effector functions and clear cell debris.  FPR have also recently been identified in hepatocytes, immature dendritic cells, astrocytes, microglial cells, and the tunica media of coronary arteries.  Known FPR ligands include formylated peptides, annexin I (lipocortin I) and selected HIV-1 envelope proteins.  FPR have been proposed as prospective targets for therapeutic intervention against malignant gliomas. A flow cytometry based high throughput screening (HTS) campaign was undertaken to identify novel small molecule FPR ligands. A set of compounds was identified for the physical screening on the basis of preliminary virtual screening of ~480,000 drug-like small molecules from Chemical Diversity Laboratories, Inc (San Diego, CA). The virtual screen employed a FPR homology model based on the bovine rhodopsin crystal structure and a pharmacophore based on known FPR ligands. The FPR assay measured the ability of test compounds to compete with a high-affinity fluorescent ligand, fMLFK-FITC, for binding to cell membrane FPR. For assay performance, additions to wells were in sequence as follows: 1st, test compounds and control reagents (5 microL/well); 2nd, U937 cells expressing transfected human FPR (107/mL, 5 microL/well); 3rd, (after 30 min, 4C incubation) fMLFK-FITC (5 microL/well, Kd = 3 nM).  After an additional 45 min, 4C incubation, plates are immediately analyzed by flow cytometry. The assay response range is defined by replicate control wells containing unlabeled fMLFF (4Pep) receptor blocking peptide or buffer.   Test compounds are assessed for the ability to inhibit peptide binding, detected as a decrease in cell fluorescence due to displacement of fluorescent fMLFK-FITC from FPR.  Compounds inhibiting 65% or more are considered active, subject to further evaluation.  The assay is homogeneous in that cells, compounds and fluorescent peptide are added in sequence and the wells subsequently analyzed without intervening wash steps.  The HyperCyt high throughput flow cytometry platform is used to sequentially sample cells from wells (2 microL/sample) for flow cytometer presentation. The resulting time-resolved data files are analyzed with IDLQuery software.
bao:BAO_0000812 "1202" ; # "has summary assay" -> "1202"
bao:BAO_0000808 bao:BAO_0000031 ; # "has primary assay" -> "primary assay"
bao:BAO_0000205 bao:BAO_0000219 ; # "has assay format" -> "cell-based format"
bao:BAO_0000409 bao:BAO_0000410 ; # "assay measurement type" -> "endpoint assay"
bao:BAO_0002850 bao:BAO_0000534 ; # "has assay readout content" -> "single readout"
bao:BAO_0002851 "single parameter" ; # "has assay readout content parametricity" -> "single parameter"
bao:BA0_0090012 bao:BAO_0000284 ; # "has participant" -> "G protein coupled receptor" || bao:BAO_0003102 bao:BAO_00020144 ; # "has role" -> "target"
bao:BAO_0002855 bao:BAO_0000110 ; # "is bioassay type of" -> "protein-small molecule interaction assay"
bao:BAO_0000212 bao:BAO_0000123 ; # "has assay method" -> "binding assessment method"
bao:BAO_0000207 bao:BAO_0000005 ; # "has detection method" -> "flow cytometry"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Antagonists of the Formyl Peptide Receptor 1 (FPR1)" ; # "screening campaign name" -> "Antagonists of the Formyl Peptide Receptor 1 (FPR1)"
bao:BAO_0002853 "Formylpeptide Receptor Ligand Binding Assay" ; # "has assay title" -> "Formylpeptide Receptor Ligand Binding Assay"
bao:BAO_0003105 <http://purl.obolibrary.org/obo/GO_0005488> ; # "has function" -> "binding"
bao:BAO_0002867 bao:BAO_0000513 ; # "has assay footprint" -> "96 well plate"
bao:BAO_0002863 bao:BAO_0000536 ; # "has concentration throughput" -> "single concentration"
bao:BAO_0000109 "4 degree celsius" ; # "has temperature value" -> "4 degree celsius"
bao:BAO_0002833 "45 minute" ; # "has incubation time value" -> "45 minute"
bao:BA0_0090012 "unlabeled fMLFF peptide" ; # "has participant" -> "unlabeled fMLFF peptide"
bao:BAO_0000740 bao:BAO_0000080 ; # "has assay control" -> "positive control" || bao:BAO_0003102 <http://purl.obolibrary.org/obo/CHEBI_35225> ; # "has role" -> "buffer"
bao:BAO_0000740 bao:BAO_0000079 ; # "has assay control" -> "negative control"
bao:BAO_0002020 bao:BAO_0000373 ; # "has assay phase characteristic" -> "heterogeneous phase"
bao:BAO_0000118 "1%" ; # "DMSO" -> "1%"
bao:BA0_0090012 bao:BAO_0000909 ; # "has participant" -> "fMLFK-FITC" || bao:BAO_0003102 bao:BAO_00020143 ; # "has role" -> "substrate"
bao:BA0_0090012 "fMet-Leu-Phe receptor" ; # "has participant" -> "fMet-Leu-Phe receptor"
bao:BAO_0002004 bao:BAO_0000758 ; # "has cell line" -> "U937 (CD59+)"
bao:BAO_0002921 <http://purl.obolibrary.org/obo/NCBITaxon_9606> ; # "has organism" -> "Homo sapiens"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "2357" ; # "gene ID" -> "2357"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "P21462" ; # "uniprot ID" -> "P21462"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "9606" ; # "NCBI taxonomy ID" -> "9606"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "10% fetal bovine serum" ; # "material entity culture serum" -> "10% fetal bovine serum" || bao:BAO_0003102 bao:BAO_0002596 ; # "has role" -> "culture serum"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "\"RPMI 1640 with 10% FBS, 2 mM?L-glutamine, 10 mM HEPES, 10 U/ml penicillin, 10 microg/ml streptomycin, 4 microg/ml ciprofloxacin, and 500 microg/ml Geneticin\"" ; # "material entity culture medium" -> ""RPMI 1640 with 10% FBS, 2 mM?L-glutamine, 10 mM HEPES, 10 U/ml penicillin, 10 microg/ml streptomycin, 4 microg/ml ciprofloxacin, and 500 microg/ml Geneticin"" || bao:BAO_0003102 bao:BAO_0000114 ; # "has role" -> "culture medium"
bao:BAO_0000212 bao:BAO_0000246 ; # "has assay method" -> "stable transfection"
bao:BAO_0000550 "Expressing human formyl peptide receptor 1 (FPR1)" ; # "DNA construct" -> "Expressing human formyl peptide receptor 1 (FPR1)"
bao:BAO_0003105 "formyl peptide receptor 1" ; # "has function" -> "formyl peptide receptor 1"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "2357" ; # "construct gene ID" -> "2357"
bao:BAO_0002662 bao:BAO_0000643 ; # "has quality" -> "mutated"
bao:BAO_0002897 bao:BAO_0000360 ; # "has preparation method" -> "recombinant expression"
bao:BAO_0002000 bao:BAO_0002001 ; # "has measured entity" -> "measured entity"
bao:BAO_0002857 bao:BAO_0000261 ; # "has signal direction" -> "signal decrease corresponding to inhibition"
bao:BA0_0090012 bao:BAO_0000176 ; # "has participant" -> "small molecule" || bao:BAO_0003102 bao:BAO_00020137 ; # "has role" -> "perturbagen"
bao:BAO_0000212 bao:BAO_0000574 ; # "has assay method" -> "single perturbagen"
bao:BAO_0000737 bao:BAO_0000802 ; # "has manufacturer" -> "ChemDiv" || bao:BAO_0003102 bao:BAO_0002627 ; # "has role" -> "compound library manufacturer"
bao:BAO_0002865 bao:BAO_0000943 ; # "uses detection instrument" -> "HyperCyt High Throughput Flow Cytometry System"
bao:BAO_0000737 bao:BAO_0000946 ; # "has manufacturer" -> "IntelliCyt Corporation" || bao:BAO_0003102 bao:BAO_0002628 ; # "has role" -> "instrumentation manufacturer"
bao:BAO_0002917 "488 nanometer" ; # "has excitation wavelength value" -> "488 nanometer"
bao:BAO_0002918 "515 - 545 nanometer" ; # "has emission wavelength value" -> "515 - 545 nanometer"
bao:BAO_0000337 bao:BAO_0000201 ; # "has percent response" -> "percent inhibition"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "1" ; # "PubChem TID" -> "1"
bao:BAO_0000182 <http://purl.org/obo/owl/UO#UO_0000187> ; # "has response unit" -> "percent"
bao:BAO_0002787 "1" ; # "has concentration-point number" -> "1"
bao:BAO_0000196 bao:BAO_0000441 ; # "has mode of action" -> "competitive binding"
bao:BAO_0002864 bao:BAO_0000136 ; # "has repetition throughput" -> "single repetition"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "mp" ; # "Annotated by" -> "mp"
